enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. United States v. Arthrex, Inc. - Wikipedia

    en.wikipedia.org/wiki/United_States_v._Arthrex,_Inc.

    Arthrex, Inc., 594 U.S. ___ (2021), was a United States Supreme Court case related to the Appointments Clause of the United States Constitution as it related to patent judges on the Patent Trial and Appeal Board (PTAB). In a complex decision, the Court ruled that these judges were considered "principal officers" under the Appointments Clause ...

  3. List of United States Supreme Court patent case law

    en.wikipedia.org/wiki/List_of_United_States...

    Patent applicants who are unhappy with the final decision of the USPTO's Patent Trial and Appeal Board have two options to appeal: they can appeal to the Federal Circuit (which conducts a limited review of the Patent Trial and Appeal Board's decision) or sue the USPTO Director in the Eastern District of Virginia (which can consider new evidence ...

  4. Intel wins US appeal to overturn $2.18 billion VLSI patent ...

    www.aol.com/news/intel-wins-us-appeal-overturn...

    WASHINGTON (Reuters) -A U.S. appeals court on Monday threw out a $2.18 billion patent-infringement award won by patent owner VLSI Technology against Intel Corp, overturning one of the largest ...

  5. Microsoft hit with $242 million US verdict in Cortana patent ...

    www.aol.com/news/microsoft-hit-242-million-us...

    Microsoft must pay patent owner IPA Technologies $242 million, a federal jury in Delaware said on Friday after determining that Microsoft's Cortana virtual-assistant software infringed an IPA patent.

  6. Moderna wins COVID shot patent case against Pfizer ... - AOL

    www.aol.com/news/moderna-wins-case-patent...

    (Reuters) -Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer and BioNTech.

  7. Amgen Inc v. Sanofi - Wikipedia

    en.wikipedia.org/wiki/Amgen_Inc_v._Sanofi

    Amgen Inc. v. Sanofi, 598 U.S. 594 (2023), is a United States Supreme Court case in which the Court held that Amgen's two patent applications on cholesterol-lowering drugs failed to satisfy the enablement clause of §112 of the Patent Act, 35 U.S.C. § 112(a).

  8. Bayer's patent for blood thinner Xarelto invalid, UK ... - AOL

    www.aol.com/news/bayers-patent-blood-thinner...

    Bayer's patent covering its best-selling blood thinner Xarelto is invalid, London's High Court ruled on Friday in a blow to the German drugmaker. The company's blockbuster Xarelto drug generated ...

  9. List of United States patent law cases - Wikipedia

    en.wikipedia.org/wiki/List_of_United_States...

    This is a list of notable patent law cases in the United States in chronological order. The cases have been decided notably by the United States Supreme Court, the United States Court of Appeals for the Federal Circuit (CAFC) or the Board of Patent Appeals and Interferences (BPAI). While the Federal Circuit (CAFC) sits below the Supreme Court ...